Ligand Pharmaceuticals, Inc. (NASDAQ:LGND)

CAPS Rating: 4 out of 5

Develops and markets new drugs that address critical unmet medical needs in the areas of cancer, mens and womens health, skin diseases, osteoporosis, and metabolic, cardiovascular and inflammatory diseases.

Recs

1
Player Avatar AndrewGreenBull (99.06) Submitted: 9/6/2009 12:01:22 PM : Outperform Start Price: $14.28 LGND Score: -38.74

you can hold it life long

Featured Broker Partners


Advertisement